IFNL3 and Cirrhosis: This finding could be valuable because the patient with TT genotype and cirrhosis had the priority for treatment despite significantly lower SVR as also recommended by El-Khayat et al. [11], and IL28B (rs12979860) SNPs could be used as a genetic predictor to assess the risk of fibrosis progression in chronic HCV patients.